CASE REPORT |
|
Year : 2011 | Volume
: 26
| Issue : 4 | Page : 188-191 |
|
Oncogenic osteomalacia diagnosed by blood pool scintigraphy
Shanmuga Sundaram Palaniswamy1, Padma Subramanyam1, Harish Kumar2
1 Department of Nuclear Medicine and PET/CT, Amrita Institute of Medical Sciences and Research Center, Cochin, Kerala, India 2 Department of Endocrinology, Amrita Institute of Medical Sciences and Research Center, Cochin, Kerala, India
Correspondence Address:
Shanmuga Sundaram Palaniswamy Consultant and Head, Department of Nuclear Medicine and PET/CT, Amrita Institute of Medical Sciences and Research Centre, Cochin - 680 2041, Kerala India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0972-3919.106702
|
|
Oncogenic osteomalacia is a rare metabolic bone disease characterized by phosphaturia and hypophosphatemia. Certain tumors secrete a phosphaturic factor, which results in this metabolic abnormality; this factor called as phosphatonin, is in fact a fibroblast growth factor 23 (FGF-23) involved closely in phosphate homeostasis and skeletogenesis. Complete excision of these tumors facilitates reversal of the problem. We have reported here the case of a patient who was crippled with this disease and on thorough investigation revealed an oncogenic osteomalacia with tumor focus in the right tibia. The tumor was identified as a mesenchymal tumor, i.e., hemangiopericytoma. Tumor excision alleviated patient symptoms with rapid symptomatic and biochemical improvement. |
|
|
|
[FULL TEXT] [PDF]* |
|
 |
|